ARTICLE | Clinical News
Carfilzomib: Phase III start
February 8, 2010 8:00 AM UTC
This half, Onyx plans to begin the open-label, international Phase III "009" trial in 700 patients to evaluate lenalidomide and low dose dexamethasone with or without carfilzomib. Onyx has an SPA from...